Accelerated rTMS vs. Sham for Stroke Apathy
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT07113067
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Abulia
- Apathy
- Motivation
- Stroke
- Stroke Sequelae
- Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic)
- Stroke/Brain Attack
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active) — DEVICEActive treatment will consist of high-dose iTBS-rTMS to left dmPFC delivered in runs of 600 pulses at an intensity of 120% resting motor threshold (rMT). iTBS triplets at 50 Hz will be delivered for 2 seconds, repeated every 10 seconds for a total of 190 seconds. Each session will be separated by at least 10-15 minutes and a total of 12 sessions will be given on each treatment day (3-4 hours per study day). A total of 43,200 pulses will be delivered over the entire six days of treatment.
- MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham) — DEVICEFor the sham stimulation group, a focal electric sham will be used which is indistinguishable from active TMS including a pretreatment individualized sham titration, sham outputs noises synchronized to pulse delivery, and an individualized level of sham stimulation throughout the treatment. Technicians administering active vs sham TMS will be masked by using a random code generated by the statistician that will indicate whether to use the active or sham side of the coil. Treatments will appear identical to the technician regardless of whether active or sham TMS is administered.
- Brainsight Neuronavigation System — OTHERA brainsight neuronavigation system will be used during TMS treatments to target treatment location using individual MRI data
Study Details
Apathy is a common set of symptoms seen in many people following a stroke. Apathy occurs when a person has lost motivation, becomes withdrawn, and stops doing things that used to be important to them. Apathy has a large negative impact on a person's quality of life, and can also have a large impact the people who take care of them. There are currently no FDA-approved treatments to help with apathy, and other services like therapy may be difficult to access for people who have had a stroke. To address this problem, investigators are conducting a study to find out if a form of treatment called repetitive transcranial magnetic stimulation (rTMS) can be safe and helpful for people struggling with apathy after a stroke. This study will apply a new form of rTMS which can be delivered quickly to a part of the brain called the medial prefrontal cortex (mPFC). This study will help establish whether this treatment is safe, comfortable, and effective for people with apathy after a stroke, and will help researchers develop new forms of treatment.
Key Dates
- Start date
- Aug 8, 2025
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active TMSThis group will receive active accelereated iTBS-rTMS
- Sham Comparator: Sham TMSThis group will receive sham accelerated iTBS-rTMS
Primary Outcome Measure
Change in apathy symptoms, as measured by the Lille Apathy Rating Scale (LARS) compared to baseline [ Time Frame: Pre-treatment, immediately post-treatment, and at one month post-treatment follow-up ]
Central Contacts
- Parneet Grewal, MD843-792-3020
- Lisa McTeague, PhD843-792-8274
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina Brain Stimulation Lab | Charleston | South Carolina | 29403 |
Find similar trials in Charleston, SC
Related Studies
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Escitalopram and Language Intervention for Subacute AphasiaPHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Telerehabilitation for Aphasia (TERRA)Recruiting · University of South Carolina · Columbia, South Carolina
- Exercise Primed Stroke RehabilitationEARLY_PHASE1 · Recruiting · VA Office of Research and Development · Charleston, South Carolina